Yes, phenibut is addictive. It acts on the same brain systems as alcohol and benzodiazepines, produces tolerance with regular use, and causes a withdrawal syndrome severe enough to require hospitalization in many documented cases. Despite being sold online as a supplement or “nootropic,” phenibut carries real dependence risk, and stopping abruptly after daily use can be dangerous.
How Phenibut Works in the Brain
Phenibut is a synthetic compound originally developed in Russia as an anti-anxiety medication. It works primarily by binding to two targets in the brain: GABA-B receptors, which are the same receptors targeted by the muscle relaxant baclofen, and a specific part of voltage-gated calcium channels that’s also the target of gabapentin, a prescription drug used for nerve pain and seizures.
The calcium channel binding is actually the stronger of the two. Research published in a pharmacology study found that phenibut’s active form binds to these calcium channels with roughly four to five times greater affinity than it binds to GABA-B receptors. This dual action is part of why phenibut produces such a noticeable effect: it both calms anxiety through the GABA system and reduces excitatory signaling through calcium channels. The result is a feeling of relaxation, reduced social anxiety, and mild euphoria that users find reinforcing, which is exactly the combination that drives repeated use.
How Quickly Tolerance Develops
Tolerance to phenibut develops with regular use, meaning you need increasing amounts to get the same effect. In clinical case reports, the pattern is consistent: people start at relatively low doses and escalate over weeks or months. In Russia, where phenibut is a prescription medication, therapeutic doses are modest. But case reports of addiction describe daily intake reaching 8 grams or more, which is many times higher than any clinical dose.
One well-documented case involved a patient who had been using phenibut daily for 10 months and had escalated to 8 grams per day. This kind of dose creep is characteristic of substances that produce tolerance. A systematic review of 62 cases found that among people hospitalized for phenibut withdrawal, 95.7% reported daily use beforehand. The typical user profile was male (80.7% of cases), with an average age of about 31, and 86.8% had purchased phenibut online. Notably, 63.2% were also using other substances, most commonly benzodiazepines or alcohol, which act on similar brain pathways and compound the risk.
What Withdrawal Looks Like
Phenibut withdrawal closely resembles alcohol withdrawal, and in severe cases it can be just as dangerous. The most commonly reported symptoms are anxiety, agitation, insomnia, and psychosis. More severe cases involve delirium, hallucinations, tremors, and seizures.
A systematic review of 25 withdrawal cases found that symptoms tend to worsen quickly. Sixty-four percent of patients experienced worsening symptoms within the first 24 hours of seeking medical care. Seizures occurred in about 8% of cases. Twenty-four percent of patients required intubation (a breathing tube), and 44% needed intensive care. The average hospital stay for withdrawal was 7.7 days, though some patients stayed as long as 30 days. These numbers reflect a withdrawal syndrome that can escalate rapidly and unpredictably, which is why stopping phenibut cold turkey after heavy daily use is considered medically risky.
Chronic use has also been associated with depression, cognitive problems, and psychosis that may persist beyond the acute withdrawal period. Withdrawal symptoms like anxiety and insomnia can linger for weeks, sometimes requiring ongoing medication support.
How Withdrawal Is Treated
The most commonly used approach for phenibut withdrawal involves baclofen, a prescription muscle relaxant with a very similar chemical structure. Because the two drugs bind to the same GABA-B receptors, baclofen can substitute for phenibut and then be gradually tapered down. A general conversion used in clinical settings is 10 mg of baclofen for every 1 gram of phenibut. Baclofen has a lower potential for misuse than other treatment options, making it a safer bridge medication.
For moderate to severe withdrawal, doctors typically combine baclofen with benzodiazepines or barbiturates to manage acute symptoms like agitation and seizure risk. Antipsychotic medications and gabapentin-type drugs are also used in some cases. A review found that nearly 70% of phenibut withdrawal cases required multiple medications for treatment, which reflects how complex the withdrawal can be. Chronic phenibut use at high doses may require months of baclofen-supported tapering before the brain fully adjusts.
Why Phenibut Falls Through Regulatory Gaps
Phenibut occupies an unusual legal space in the United States. The FDA has stated that phenibut does not meet the legal definition of a dietary ingredient, meaning any supplement listing it on the label is technically misbranded. The agency has issued warning letters to companies selling phenibut products and, in 2023, obtained a federal court injunction against a distributor marketing phenibut-containing products. Despite this, phenibut remains widely available for purchase online, often marketed as a supplement for sleep, relaxation, or cognitive enhancement.
Phenibut is not a scheduled controlled substance in the U.S., which means it doesn’t carry the same legal penalties as drugs like benzodiazepines. It’s also invisible to standard drug testing. No commercially available test exists for phenibut, and it does not show up on routine urine drug screens, including 10-panel and 12-panel tests. This combination of easy online availability, lack of scheduling, and undetectability on drug tests contributes to its growing misuse. The CDC has tracked a rising number of phenibut-related calls to poison control centers.
Risk Factors for Dependence
Not everyone who tries phenibut becomes dependent, but certain patterns sharply increase the risk. Daily use is the clearest predictor. Nearly all hospitalized withdrawal cases involved daily users. Using phenibut alongside alcohol or benzodiazepines compounds the danger because all three substances suppress brain activity through overlapping mechanisms, and cross-tolerance can develop.
People with a history of substance use disorders appear to be at elevated risk. Case reports frequently describe patients who discovered phenibut while already struggling with alcohol or other drug dependencies. The subjective effects of phenibut, particularly anxiety relief and a sense of calm, are especially reinforcing for people who use substances to manage stress or social discomfort. Because phenibut is sold without a prescription and often framed as a harmless supplement, many users don’t recognize the dependence potential until they try to stop and experience withdrawal symptoms.